Thyroid accumulation and adverse effects of imipramine and desipramine in rats after long-term administration

Pharmacology

Volumn 57, Issue 5, 1998, Pages 242-248

  Rousseau, Annick ^a,b   Marquet, Pierre ^a   Lagorce, Jean F ^c   Sauvage, Marie F ^a,b   Buxeraud, Jacques ^b   Lachâtre, Gérard ^a   Raby, Claude ^b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c NONE

Author keywords

Adverse effect; Desipramine; Imipramine; Thyroid

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; GUM ARABIC; IMIPRAMINE; LIOTHYRONINE; THYROXINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ELIMINATION; LIOTHYRONINE BLOOD LEVEL; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID GLAND; THYROXINE BLOOD LEVEL;

ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BODY WEIGHT; DESIPRAMINE; IMIPRAMINE; MALE; RATS; RATS, WISTAR; THYROID GLAND; THYROID HORMONES;

EID: 0031666097     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028248     Document Type: Article

References (24)

1. Sauvage MF, Marquet P, Rousseau A, Raby C, Buxeraud J, Lachâtre G: Relationship between psychotropic drugs and thyroid function: A review: Toxicol Appl Pharmacol 1998;149:127-135.
2. Joffe RT, Singer W: The effects of tricyclic antidepressants on basal thyroid hormone levels in depressed patients. Pharmacopsychiatry 1990; 23:67-69.
3. Balon R, Pohl R, Yeragani VK, Ramesh C, Glitz DA: The changes of thyroid hormone during pharmacological treatment of panic disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 1991;15:595-600.
4. Joffe RT, Nobrega J, Kish S, Calvo R, Dixon L, Wilson J: Desipramine reduces plasma but not brain thyroxine levels. Biol Psychiatry 1993; 33:293-294.
5. Campos-Barros A, Baumgartner A: Effects of chronic desipramine treatment on thyroid hormone concentrations in rat brain: Dependency on drug dose and brain area. Biol Psychiatry 1994;35:214-216.
6. 125I-labeled thyroid hormones in rat brain. Brain Res 1993;626:175-183.
7. Atterwill CK, Catto LC, Heal DJ, Holland CW, Dickens TA, Jones CA: The effects of desipramine (DMI) and electroconvulsive shock (ECS) on the function of the hypothalamo-pituitary-thyroid axis in the rat. Psychoneuroendocrinology 1989;14:339-346.
8. Buxeraud J, Absil, AC, Raby C: Secondary antithyroid action of drugs in relation to structures. J Pharm Sci 1984;73:1687-1690.
9. Buxeraud J, Absil AC, Claude J, Raby C, Catanzano G, Beck C: Antithyroïdiens: Relation structure-activité. II. Interprétation du mécanisme d'action des A.T.S. par complexation de transfer de charge. Eur J Med Chem 1985;20:43-51.
10. Raby C, Lagorce JF, Jamburt-Absil AC, Buxeraud J, Catanzano G: The mechanism of action of synthetic antithyroid drugs: Iodine complexation during oxidation of iodide. Endocrinology 1990;126:1683-1691.
11. Rousseau A, Comby F, Buxeraud J, Raby C: Spectroscopic analysis of charge transfer complex formation and peroxidase inhibition with tricyclic antidepressant drugs: Potential antithyroid action. Biol Pharm Bull 1996;19:726-728.
12. Comby F, Lagorce JF, Moulard T, Buxeraud J, Raby C: Sulfamides antibactériens, antiparasitaires et antifongiques dérivés de l'imidazole: évaluation des effects antithyroidiens sur le rat. Vet Res 1993;24: 316-326.
13. Comby F, Lagorce JF, Buxeraud J, Raby C: Antithyroid action of ketonazole: In-vitro studies and rat-invivo studies. J Pharm Pharmacol 1994;46:50-53.
14. Rousseau A, Marquet P, Comby F, Buxeraud J, Raby C, Lachâtre G: Sensitive microanalysis of imipramine and desipramine in single rat thyroids by gas chromatography-mass spectrometry. J Chromatogr 1997;693:93-100.
15. Gram LF, Bjerre M, Kragh-Soren-sen P, Kvinesdal B, Molin J: Imipramine metabolites in blood of patients during therapy and after overdose. Clin Pharmacol Ther 1983;33: 335-342.
16. Argenti D, D'Mello P: The pharmacodynamics of desipramine and desmethyldesipramine in rats. J Pharmacol Exp Ther 1994;270:512-519.
17. Martin P, Massol J, Belon JP, Gaudel G, Soubrie P: Thyroid function and reversal by antidepressant drugs of depressive-like behavior (escape deficits) in rats. Neuropsychobiology 1987;18:21-26.
18. Besret L, Debruyne D, Rioux P, Bonvalot T, Moulin M, Zarifian E, Baron JC: A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat. J Pharm Sci 1996;85:291-295.
19. Opitz K, Akinlaja A: Zur Beeinflussung der Nahrungsaufnahme durch Psychopharmaka. Psychopharmacology (Berl) 1966;9:307-319.
20. Dratman MB, Crutchfield FL, Gordon JT, Jenning AS: lodothyronine homeostasis in rat brain during hypo- and hyperthyroidism. Am J Physiol 1983;8:E185-E193.
21. Joffe RT, Sokolov ST: Thyroid hormones, the brain, and affective disorders. Crit Rev Neurobiol 1994;8: 45-63.
22. Duval F, Mokrani MC, Crocq MA, Jautz M, Bailey P, Diep TS, Macher JP: Effect of antidepressant medication on morning and evening thyroid function tests during a major depressive episode. Arch Gen Psychiatry 1996;53:833-840.
23. Joffe RT, Levitt AJ: The thyroid and depression; in Joffe RT, Levitt AJ (eds): The Thyroid Axis and Psychiatric Illness. Washington, American Psychiatric Press, 1993, pp 193-253.
24. Joffe R, Segal Z, Singer W: Change in thyroid hormone levels following response to cognitive therapy for major depression. Am J Psychiatry 1996;153:411-413.